Why is CPATTM the World-Leading Course in Psychedelic-Assisted Therapies?
The Certificate in Psychedelic-Assisted Therapies (CPAT)TM stands out globally for its depth, quality and career impact.
-
World-Class Faculty
Learn from international experts, including Dr Bessel van der Kolk, Dr Gabor Maté and Professor David Nutt. Learn more about the faculty.
-
Comprehensive Training
127+ CPD-accredited hours combining online learning and residential intensives.
-
Exceptional Feedback
Graduates describe it as one of the most valuable trainings of their entire careers. Read testimonials.
-
Lifelong Community
Join an active alumni network with access to regular alumni PD, supervision, and peer support.
-
Clinical Experience
Gain real-world opportunities at the Mind Medicine Australia Clinic and Centre of Excellence and introductions to other PAT Clinics around Australia.
-
Career Pathways
Open doors to roles within MMA and other organisations in the growing psychedelic-assisted therapies field.
-
Outstanding Value
High-quality education with strong return on investment.
“The most rounded professional development I can remember doing - I felt nourished in mind, soul and body.”
“In my 30 years of work as a psychologist, I have never attended such an engaging and informative course of this calibre.”
About the Course
Psychedelic-assisted therapies (PAT) are delivered by treatment teams with three main roles: prescriber, primary therapist and secondary therapist. This course has been developed to address the training needs for the three roles, recognising the desirability of members of PAT teams to understand the entire PAT treatment process and the roles each assumes. The Certificate in Psychedelic-Assisted Therapy course provides appropriately qualified and experienced healthcare professionals with the necessary capabilities, knowledge and skills to safely and successfully facilitate PAT in a clinical environment, in accordance with their role as prescriber, or primary or secondary therapist.
Please note: Psychiatrists are responsible for prescribing psychedelic medicines. However, they work as part of a multidisciplinary team including other mental health professionals to deliver treatment. This world-class training program is suitable for both prescribers and therapists.
Prescribers: For those who have the necessary qualifications to prescribe psychedelic medicines, this course will equip them with the knowledge and skills to create and document a PAT treatment protocol, and safely prescribe specific psychedelic medicines for specific mental health conditions.
Therapists: The course will prepare appropriately qualified and experienced healthcare professionals with the skills and knowledge necessary to safely and effectively support patients undergoing PAT as primary or secondary therapists. Note that the ability to practice as a primary therapist in PAT is also dependent on prior relevant clinical experience in psychotherapy.
Training focuses on evidence-based, standardised approaches to PAT that may be integrated with clinicians’ existing psychotherapeutic experience and clinical practice. The course includes a combination of face-to-face and online learning and self-study. It is delivered over 14 weeks of online learning and a 6-day full-time, face-to-face residential workshop. The main psychedelic medicines this course focuses on are MDMA, psilocybin and ketamine.
Training of prescribers and therapists occurs together, reflective of the holistic team approach that characterises PAT. In previous iterations of the course, learners have given positive feedback specifically about the value of training together. However, whilst the curriculum is the same for all learners enrolled, in recognition of the unique roles and levels of responsibility of prescribers and therapists, assessment tasks differ for prescribers and therapists and serve to differentiate the CPAT award into two distinct awards: the CPAT-Prescriber and the CPAT-Therapist. Only psychiatrists and medical practitioners will be eligible to complete the assessment for Prescribers and be awarded the CPAT-Prescriber. The awards of CPAT-Prescriber and CPAT-Therapist are dependent on successful completion of all assessment items.
The Faculty
Dr Gita Vaid (USA)
Dr Gabor Maté CM (Canada)
Dr Eli Kotler (AUS)
Dr Bessel van der Kolk (USA)
Dr Peter Levine (USA)
Dr Lauren Macdonald (UK)
Rabbi Tirzah Firestone (USA)
Professor David Nutt (UK)
Dr James Fadiman (USA)
Dr Rick Doblin (USA)
Dr William (Bill) Richards (USA)
Dr David Erritzoe (UK)
Dr Philip Wolfson (USA)
Licia Sky (USA)
Bianca King (Switzerland)
Dr Julia King Olivier (Switzerland)
Dr Charles Nichols (USA)
Jeff Leifer (USA)
Sara Reed (USA)
Dr Janelle Trees (AUS)
Namae Ntumae (USA)
Dr Ashleigh Murphy-Beiner (UK)
Ivar Goksøyr (Norway)
Dr Joe Tafur (USA)
Dr Stephen Proud (AUS)
Dr. Maria-Elena Lukeides (AUS)
Jimena Doval Clarke (AUS)
Francoise Bourzat (USA)
Trudi Hayes (AUS)
Tania de Jong AM
Peter Hunt AM
Scott Edwards
Emma Park
Dr Gita Vaid MD is CPAT’s International Course Director.
Dr Gita Vaid is a Board Certified Psychiatrist and psychoanalyst practicing in New York City. Dr Vaid completed her residency training at NYU Medical Center and her psychoanalytic training at the Institute for Psychoanalytic Education affiliated with NYU. Her early biological and research background includes a completed fellowship in clinical psychopharmacology and neurophysiology at New York Medical College and a research fellowship at NYU Medical Center.
Dr Vaid is currently on faculty and teaches at both IPE and the NYU department of Psychiatry. She has a special interest in teaching interview technique, psychoanalytic theory and British object relations.
Dr Vaid’s current focus and expertise are in psychedelic-assisted psychotherapy. She is a MAPS trained psychedelic therapist and was part of the NY site Phase 3 MDMA psychotherapy study for PTSD.
Dr Vaid is a leader in ketamine assisted psychotherapy which she practices and teaches in New York City. She serves as a lead instructor at The Ketamine Training Center with psychedelic psychotherapy pioneer, Dr. Phil Wolfson. She is a co-founder of the Center for Natural Intelligence, a multidisciplinary laboratory dedicated to psychedelic psychotherapy innovation and research. She serves as the Director of Psychedelic Awareness and Consciousness research at The Chopra Foundation and with Dr. Deepak Chopra is currently developing protocols integrating meditation with ketamine assisted psychotherapy.
Current publications include:
Vaid G, Walker B. “Psychedelic Psychotherapy: Building Wholeness Through Connection”. Glob Adv Health Med. 2022 Feb 23;11
Gita Vaid, MD, “Psychoanalysis and Psychedelic Psychotherapy : A New Modern Synthesis?” The Wounds of Our Mother Psychoanalysis – New Models for a Psychoanalysis in Crisis.
Dr Gabor Maté CM (Canada)
BA, MD, Doctor of Laws (honoris causa)
Gabor Maté (pronunciation: GAH-bor MAH-tay) is a retired physician who, after 20 years of family practice and palliative care experience, worked for over a decade in Vancouver’s Downtown East Side with patients challenged by drug addiction and mental illness. The bestselling author of five books published in 43 languages, including the award-winning In the Realm of Hungry Ghosts: Close Encounters with Addiction, Gabor is an internationally renowned speaker highly sought after for his expertise on addiction, trauma, childhood development, and the relationship of stress and illness. For his groundbreaking medical work and writing he has been awarded the Order of Canada, his country’s highest civilian distinction, and the Civic Merit Award from his hometown, Vancouver. His latest book, The Myth of Normal: Trauma, Illness & Healing in a Toxic Culture remains a Canadian best seller and was a 19-week New York Times best seller. His next book, Hello Again: A Fresh Start for Parents and their Adult Children is expected in 2027.
Dr. Eli Kotler has been on the forefront of psychedelic-assisted therapy (PAT) both in Australia and internationally, currently working at The Journey Clinic. He is the Australian Director of the Certificate of Psychedelic-Assisted Therapy (CPAT), run by Mind Medicine Australia. In 2021 he challenged the Victorian government in court to allow a patient to access PAT, and was the first psychiatrist in Australia to treat a patient with PAT.
Dr. Kotler is also an experienced psychodynamic therapist. He was the Medical Director of Malvern Private Hospital for many years, a trauma and addiction hospital in Melbourne. He has been invited as a keynote speaker on PAT, trauma and addiction, both internationally and nationally, for leading organisations such as the RANZCP and the IPA. Eli has also been an advisor for the Australian government for reviewing addiction guidelines, and has had extensive research experience in novel neuropsychiatric therapies.
Dr. Kotler has been involved with medical student teaching, psychiatric registrar training, and teaching other psychiatrists about PAT and trauma. He is a preferred provider for the AFL players association, has been an expert witness in over 100 historical abuse legal cases, and served on the Victorian Medical Panels for several years.
Dr Bessel van der Kolk MD, Professor of Psychiatry, Boston University School of Medicine and President, Trauma Research Foundation, has spent his career studying how children and adults adapt to traumatic experiences, and have tried to translate emerging findings from pharmacology, neuroscience and attachment research to develop and study potentially effective treatments for traumatic stress in children and adults.
In 1984, Dr van der Kolk set up one of the first clinical/research centers in the US dedicated to study and treatment of traumatic stress in civilian populations, which has trained numerous researchers and clinicians specializing in the study and treatment of traumatic stress, and which has been continually funded to research the impact of traumatic stress and effective treatment interventions. He conducted the first studies on the effects of SSRIs on PTSD; he was a member of the first neuroimaging team to investigate how trauma changes brain processes, and he did the first research linking BPD and deliberate self-injury to trauma and neglect in early childhood.
Currently, Dr van der Kolk is Principal Investigator of the Boston arm of the MAPS 1 and 2 studies on the effects of MDMA on people with chronic PTSD. His seminal book The Body keeps the Score , has been on the New York Times best seller list for over 230 weeks, and has been translated into 42 different languages.
Dr Peter Levine (USA)
Somatic Therapist and Founder of Somatic Experiencing®
Peter A. Levine, Ph.D., is the developer of Somatic Experiencing®, a naturalistic and neurobiological approach to healing trauma, which he has developed over the past 50 years. He holds a doctorate in Biophysics from UC Berkeley and a doctorate in Psychology. He is the Founder and President of the Ergos Institute of Somatic Education and the Founder and Advisor for Somatic Experiencing International, where his work has been taught to almost 200,000 therapists in 44 countries.
He has taught at the University of California, Berkeley; Mills College; Antioch University; the California Institute of Integral Studies; and the Santa Barbara Graduate Institute, The Sigmund Freud University of Medicine in Vienna and the department of psychiatry at the school of medicine in Zurich Switzerland. He was a stress consultant for NASA on the early space shuttle mission.
He is the author of several landmark books on trauma, including Waking the Tiger, Healing Trauma (published in over 33 languages); In an Unspoken Voice, How the Body Releases Trauma and Restores Goodness; and Trauma and Memory, Brain and Body in a Search for the Living Past. And in 2025 published, An Autobiography of Trauma, A Healing Journey.
Dr Lauren Macdonald is one of CPAT’s Residential Facilitators.
She is a psychiatry doctor, psychedelic therapy guide and group facilitator. For the last few years she has been a clinical trial doctor at The Centre for Psychedelic Research (Imperial College London) investigating psilocybin-assisted therapy for anorexia-nervosa, chronic pain, and treatment-resistant depression.
Alongside her clinical roles Lauren regularly facilitates psilocybin retreats in The Netherlands, and is co-founder of Essence Medicine, an organisation providing psycho-spiritual group support to people facing life threatening illness. Lauren is also passionate about educating future psychedelic facilitators and delivers integrative, experiential and heart-centred training for Mind Medicine (Australia) and PsyEdu (UK).
Lauren has trained in medicine, psychology, MDMA-assisted therapy, and yoga, and continues to be a student of earth-based, indigenous wisdom traditions. She is driven to help people come home to themselves, unfold more of who they truly are, and deepen into the beauty and mystery of life.
Rabbi Tirzah Firestone, Ph.D., is an author, Jungian psychotherapist, a leader in the international Jewish Renewal Movement, and a renowned Jewish scholar and teacher. Widely known for her groundbreaking work on Kabbalah, depth psychology, and the re-integration of the feminine wisdom tradition within Judaism, Rabbi Tirzah lectures and teaches internationally about spiritual and ancient wisdom practices that are honed to assist us at this critical time in world history.
Her latest work, Wounds into Wisdom: Healing Intergenerational Jewish Trauma (Monkfish, 2019) is the recipient of the 2020 Nautilus Book Award Gold in Psychology and the Jewish Women’s Caucus of the Association for Women in Psychology 2020 book award.
Professor David Nutt (UK)
BA, MB BChir, MRCP, MA, DM, MRC Psych, FRCPsych, FMedSci, FRCP, FSB
Professor David Nutt is a renowned researcher, policy advisor and author, who is currently Head of Neuropsychopharmacology at Imperial College London.
Under the leadership of Professor Nutt, the Psychedelic Research Group at Imperial College is one of the world’s foremost psychedelic research laboratories, publishing landmark research on psychedelic therapies and neuroimaging studies of the psychedelic state.
Professor Nutt has also held many leadership positions in both UK and European academic, scientific and clinical organisations, including presidencies of: the European Brain Council, the British Neuroscience Association, the British Association of Psychopharmacology, the European College of Neuropsychopharmacology.
He was previously Chair of the UK Advisory Council on the Misuse of Drugs.
Dr James Fadiman B.A. (Harvard) M.A., Ph.D. (Stanford) began his personal psychedelic research a few weeks before starting his graduate work at Stanford where he did his dissertation on the effectiveness of LSD-assisted therapy. During the research lull of 40 years, he has held a variety of teaching (San Francisco State, Brandeis, and Stanford) consulting, training, counseling and editorial positions. He has taught in psychology departments, design engineering, and for three decades, at the Institute of Transpersonal Psychology (now Sofia University) that he co-founded.
James has published textbooks, professional books, a self-help book, a novel, and a series of videos, Drugs: the children are choosing for National Public Television. His books have been published in 8 languages. He has been the subject of a one-hour documentary released by Page3 Films, featured in a National Geographic documentary and had three solo shows of his nature photography.
James had his own consulting firm and sat on two non-profit boards as well as having been the president of several small natural resource companies. He has been involved in researching psychedelic for spiritual, therapeutic and creative uses and is known for his pioneering work on microdosing . He has published The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys, and most recently, Your Symphony of Selves: Discover and Understand More of Who You Are. The book he is writing now has the working title All About Microdosing.
Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and empty rooms from three children who are all in college or recently graduated.
Dr William A. Richards (Bill), author of Sacred Knowledge: Psychedelics and Religious Experiences, is a Senior Advisor at Sunstone Therapies in Rockville, Maryland (USA), currently focused on the implementation of psychedelic-assisted therapy in palliative care.
Bill also is a psychologist at the Johns Hopkins Center for Psychedelic and Consciousness Research in Baltimore, where he and his colleagues have been pursuing research with psilocybin since 1999, and teaches at the California Institute of Integral Studies and for MMA’s Certificate in Psychedelic-Assisted Therapies. Bill’s graduate degrees encompass the psychology of religion, theology, comparative religion and clinical psychology.
Bill’s involvement with psychedelic research originated in Germany at the University of Göttingen in 1963. From 1967 to 1977, he pursued research with LSD, DPT, MDA and psilocybin at the Maryland Psychiatric Research Center.
Dr. David Erritzoe is a psychiatrist and neuroscientist. He holds a Clinical Senior Lectureship (i.e. Assistant Professorship) in General Psychiatry in the Centres for Neuropsychopharmacology and Psychedelic Research at Imperial College London and CNWL Mental Health NHS Foundation Trust. Following training in neuroreceptor PET imaging at Columbia University in New York in 2002/03, he undertook a PhD at University Hospital Rigshospitalet in Copenhagen. Since moving to Imperial College in 2009 he has been conductingand overseeing clinical and neuroimaging trials (using PET, MRI, and EEG) into affective disorders and addiction. David is the Clinical Director of Imperial’s Centre for Psychedelic Research. Since early 2021 he has also headed up a new NHS-based research clinic at St Charles Hospital, the CIPPRes Clinic. He is topic lead in Psychiatry at Imperial College London’s Medical School, whilst also lecturing in MSc and BSc neuroscience programs. He has authored more than 110 peer-reviewed scientific papers and 4 book chapters.
Dr Philip Wolfson MD is Principal Investigator for the MAPS sponsored Phase 2, FDA approved 18-person study of MDMA Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine Assisted Psychotherapy. Phil’s book The Ketamine Papers has been published by MAPS and is the seminal work in the burgeoning ketamine arena. Phil is a sixties activist, psychiatrist/psychotherapist, writer, practicing Buddhist and psychonaut who has lived in the Bay Area for 38 years. He is the author of Noe – A Father/Son Song of Love, Life, Illness and Death (2011, North Atlantic Books).
In the 1980s, he participated in clinical research with MDMA (Ecstasy). He has been awarded five patents for unique herbal medicines. He is a journalist and author of numerous articles on politics, transformation, psychedelics, consciousness and spirit, and was a founding member of the Heffter Research Institute. Phil has taught in the graduate psychology programs at JFK University, CIIS and the UCSF School of Medicine Department of Psychiatry.
Licia Sky is a co-founder of the Trauma Research Foundation with Dr Bessel van der Kolk.
She is a somatic educator, artist, singer-songwriter, and bodyworker who works with traumatized individuals and trains mental health professionals to explore parts work, mindful meditation, movement, theatre exercises, psychodrama, writing, psychedelic integration, and voice as tools for attunement, healing, and connection. For the past decade, she has been teaching expanded awareness in workshops to clinicians and lay people around the world. She is a regular teacher for the Esalen Institute, Cape Cod Institute, Mind Medicine Australia and the Ketamine Training Centre.
Bianca King M.A. is a qualified and experienced Psychological Counsellor and Meditation Teacher, practicing in Geneva, Switzerland. She is co-founder with psychiatrist Dr. Julia King Olivier of the Compassionate Care Center where they carry out Psychedelic Assisted Therapy (PAT) sessions. Bianca is a qualified MAPS MDMA therapist and graduate of the CIIS CPTR training. She has been prominent in the Geneva community for running mindfulness courses for the public, the UN, and International organizations.
Throughout her life, Bianca connected with the practice of vipassana meditation and travelled to Asia to participate in teachings and retreats. She found she was learning about a dimension of the human experience that complimented her education and training in psychotherapy and psychology. For her Masters in Psychotherapy and Counselling through the University of Wales, Bianca concentrated on existential issues as she found her heart was in the work of hospice and palliative care that she had originally experienced at the Petrea King Quest for Life Foundation.
Dr Julia King Olivier (Switzerland)
MD
After obtaining her MD degree in 2000 at the University of Geneva medical school, Julia completed four years of residency training in Internal Medicine at the University Hospital of Geneva, before opting to specialize in Psychiatry. In 2010 and 2015 she earned her Swiss FMH certifications respectively for Adult Psychiatry and Psychotherapy and also for Adolescent/ Child Psychiatry and Psychotherapy. Julia uses an integrative approach drawing from a wide range of psychotherapeutic models in her practice (Freudian psychodynamic theory, Compassion Focused Therapy, EMDR and Mindfulness approaches). She also facilitates two-part ecopsychiatry workshops in natural settings, combining Shinrin Yoku (Japanese forest bathing) with Breathwork.
In 2021 she earned a Certificate in Psychedelic Assisted Therapy and Research from the California Institute of Integral Studies, and co-founded the Compassionate Care Center in Geneva Switzerland with her colleague and co-therapist Bianca King. The center provides innovative and legal psychedelic assisted therapy to Swiss residents who meet the compassionate use criteria of the Swiss Department of Public Health. She completed the five-part certification in MDMA assisted psychotherapy in 2022. Julia’s current plans involve completing the Consultancy Training to become a MAPS PBC trained Consultant and provide support to new MDMA-assisted therapy practitioners. Julia joined the Fluence training team in 2022 and co-wrote and co-facilitates a humanities focused course entitled “Poetry, symbol, story for psychedelic assisted therapy”.
Dr Charles Nichols (USA)
B.S. Ph.D
Dr. Nichols earned his B.S. at Purdue University and Ph.D. at Carnegie Mellon University. His research into 5-HT2A receptors and psychedelics began during his post-doc at Vanderbilt University nearly 30 years ago. He is currently a Professor of Pharmacology at LSU Health Sciences Center in New Orleans and is considered one of the world’s top experts on the biological effects of psychedelics in the brain and body. Key discoveries he and his laboratory have made include elucidation of the effects of psychedelics on gene expression in the brain, identification, and characterization of the specific cells in the brain that directly respond to psychedelics, and the development of new experimental systems recapitulating the long-lasting antidepressant-like effects of psilocybin for mechanistic study. The Nichols lab also discovered that psychedelics are extremely potent anti-inflammatory agents that can have full efficacy at levels far below those necessary to induce behavioral effects and is developing potential new therapies to treat inflammatory-related disorders. He is President of the International Society for Research on Psychedelics, Co-Editor in Chief of the journal Psychedelic Medicine, Vice President of the International Society for Serotonin Research, and a board member of the Heffter Research Institute.
Jeff Leifer is an impact advisor and educator in the Psychedelic Medicine space. He is the founder of Circadian, a cross-sector collaboration and experience lab building engaged, resilient communities and presenting powerful voices in the fields of innovative mental health and the study of consciousness.
Jeff co-founded the Psychedelic Research, Education and Policy (PREP) funding program at the Threshold Foundation and currently serves on the board of directors for the Ketamine Research Foundation, focused on psychedelic-assisted therapies for depression, PTSD and end of life support. Jeff also serves on the advisory board for Anuma, exploring digital group therapeutics that combine virtual reality (VR) with the science of psychedelics.
Jeff leads the Psychedelic Listening Project, which documents diverse views on the state of the psychedelic ecosystem to inform best practices for philanthropists. The project will inform stakeholders looking beyond traditional funding approaches, prioritizing models that encourage human flourishing and shared decision-making.
Jeff has also worked extensively with Indigenous communities in the Global South to support the embodiment of plant medicine lineage, traditional ecological knowledge and forest-based, economic resiliency.
Prior to launching Circadian, Jeff thrived in the world of social finance, pioneering capital reforms, collaborative governance and public finance accountability. Jeff has an MBA from Yale University and BA from the University of California at San Diego.
Sara Reed is a mental health futurist and Licensed Marriage and Family Therapist. She has spent her early career examining ways culture informs how we diagnose and treat mental illnesses. Sara has participated as a study therapist and participant in psychedelic therapy research and is currently the lead study therapist at Imperial College London for their psilocybin for OCD trial. She lectures on topics fusing culturally sensitive practices within psychedelic-assisted therapy and advises organizations on anti-oppressive and inclusive practices.
Dr. Trees, a Goori (Dhanggati) woman and GP, is a dedicated healthcare professional, often serving as the sole doctor in remote areas of Western Australia and the Northern Territory, particularly within Aboriginal communities and islands. With over thirty years of experience, she teaches locally and internationally, specialising in Indigenous health and cultures, emphasizing the importance of Indigenous knowledge for humanity’s future. Dr. Trees initially trained in Traditional Chinese Medicine as an acupuncturist before pursuing science.
An advocate for LGBTQ+ rights at the United Nations, she played a role in founding organisations like the Australian Indigenous Doctors Association (AIDA). As the first Indigenous Honours graduate from the University of Sydney School of Medicine, Dr. Trees continues to champion Indigenous values within educational systems. Beyond her medical career, she excels as an award-winning novelist in Magical Realism and Speculative Fiction.
Namae Ntumae (USA)
Namae Ntumae is the Founder & Director of CWays Home, an Oregon based animistic, educational non-profit. Its core mission is to create experiences for people to come home to themselves, to each other and with the Earth. Namae has over 30 years of experience as an educator of altered states of consciousness in Australia and America. She designed and teaches an intense, 3-year experiential training program for facilitators working with non-ordinary states of awareness, as well as educational programs for the promotion of loving consciousness for guides, therapists and researchers who are using plant medicines. Her work holds love as the core condition necessary for effective transformational change, in direct relationship with Nature’s intelligence.
Dr Ashleigh Murphy-Beiner (UK)
Ashleigh is a Clinical Psychologist, working with The Tavistock Trauma Service in the UK National Health Service and the Centre for Psychedelic Research at Imperial College London. As a clinician, Ashleigh specialises in the treatment of complex trauma and has worked as a therapist on Imperial’s clinical trials of psychedelic-assisted therapy. In her clinical research, Ashleigh carries out qualitative and psychotherapy process research to better understand clients and practitioners’ experiences of using psychedelic-assisted therapy to treat complex PTSD, depression and anorexia. Ashleigh has co-designed the ARC ethics framework with Dr. Meg Spriggs and colleagues to support the development of safe and ethical practice guidelines in psychedelic-assisted therapies. Ashleigh has also led a psychedelic integration group to help people access therapeutic and community-based peer support after having beneficial or challenging psychedelic experiences. Ashleigh is trained to work flexibly with psychodynamic, systemic, cognitive-behavioural and mindfulness-based therapies.
Ivar Goksøyr (Norway)
Ivar W. Goksøyr is a Norwegian clinical psychologist and specialist in intensive short-term psychodynamic psychotherapy, who co-founded Psykologvirke, a leading Oslo-based mental health clinic with dedicated couples therapy, trauma therapy, and general psychotherapy units, and which has also integrated ketamine-assisted psychotherapy into its services. He has been a member of the Norwegian Psychedelic Research Team (PsykForsk) since 2018 and is certified in MDMA-assisted therapy through MAPS, where he has also worked as a training assistant in MDMA-therapy trainings. Goksøyr has served as a therapist in two clinical trials of MDMA-assisted psychotherapy, one for PTSD and one for depression and for several years has led his own online training in MDMA-assisted therapy, presenting original session tapes and highlighting themes relevant for wounded healers. He has co-authored several peer reviewed articles on psychedelic science including A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy. He is currently leading the development of a study protocol on empathogen-assisted therapist development in collaboration with the University of Oslo, pioneering a new frontier in therapist development. Goksøyr co-founded Norwegian Psychedelic Science and is a leading advocate for evidence-based, responsible integration of psychedelic treatments into mainstream mental health care. He is also a prominent public communicator, sharing research and clinical perspectives through published work, national and international lectures, and regular appearances on radio, podcasts, and other media platforms.
Joe Tafur, M.D., is a Colombian-American integrative physician and author of the books The Fellowship of the River: A Medical Doctor’s Exploration into Traditional Amazonian Plant Medicine and Medicine Song: Spiritual Healing and the Psychedelic Renaissance. After completing his family medicine training at UCLA, Dr. Tafur spent two years in academic research at the UCSD Department of Psychiatry. After his research fellowship, over a period of six years, he lived and worked in the Peruvian Amazon at the traditional healing center Nihue Rao Centro Espiritual, training there as an ayahuasquero.
He eventually returned to Arizona where he completed fellowship at the Andrew Weil Center for Integrative Medicine. With his multicultural spiritual community in Phoenix, Dr. Tafur co-founded the Church of the Eagle and the Condor (CEC). Dr. Tafur is also a co-founder of the nonprofit Modern Spirit where he assists in their educational programs and guided retreats exploring the role of sacred ceremony in psychedelic therapy.
Dr Stephen Proud (AUS)
MBBS FRANZCP FAChAM Grad Dip Env Sc
Stephen Proud is a psychiatrist in private practice in regional WA with 45 years’ experience in medicine and 25 years as a psychiatrist. He has 3 sons. He has worked as a GP in rural WA, Perth and rural Zululand South Africa. He has taught GPs and psychiatric registrars for many years in Perth. He has built and run two psychiatric hospitals, one in Perth and the other an innovative rural retreat where patients lived for a month to undergo extensive psychotherapy, meditation and community living.
He has a long interest in spirituality and psychotherapy, starting with psychedelics in the 1970s, going onto humanistic psychology in California, Vipassana, The Rajneesh Ashram in India and then experience with traditional healers and Sangomas in rural Zululand. He runs meditation and psychotherapy retreats and is Monash MAPS trained in MDMA assisted therapies. He is currently involved in an MDMA trial for PTSD in Perth.
Stephen extols cooperation and is open to all groups promoting safe and sensible Psychedelic-Assisted Therapies.
Dr. Maria-Elena Lukeides is a doctorate-trained clinical psychologist with over 28 years of experience working across trauma, complex mental health, and integrative approaches to psychological healing. Her clinical background spans community and acute mental health services, early intervention in first-episode psychosis, and specialist trauma work, alongside over 15 years in private practice supporting adolescents and adults.
Dr. Lukeides has a particular interest in the treatment of trauma, depression, anxiety disorders, panic, and OCD, and brings extensive experience working with individuals presenting with both acute and long-standing psychological difficulties. Her approach is grounded in evidence-based therapies, including CBT, ACT, Internal Family Systems, and mindfulness-based interventions, with a strong emphasis on creating a safe, attuned, and effective therapeutic relationship.
In addition to her clinical psychology training, Dr. Lukeides is a mindfulness meditation and dharma teacher, as well as a trained breathwork facilitator. She integrates these modalities with contemporary psychological science to support deeper emotional processing, nervous system regulation, and sustained behavioural change.
Dr. Lukeides is among the first cohort of clinicians in Australia to deliver psychedelic-assisted therapy following the Therapeutic Goods Administration (TGA) rescheduling of psilocybin and MDMA. She has direct clinical experience working with patients in psychedelic-assisted and ketamine-assisted therapy, providing her with a grounded, practice-based understanding of both the therapeutic potential and clinical complexities of these treatments.
Her work in this space is informed by a commitment to ethical, trauma-informed care, and an integrative framework that brings together neuroscience, psychotherapy, and contemplative practice. She is particularly interested in how altered states of consciousness can be safely and effectively utilised to support healing, meaning-making, and psychological transformation.
Dr. Lukeides brings to her teaching a depth of clinical experience, a rigorous understanding of evidence-based practice, and a nuanced perspective on the evolving field of psychedelic-assisted therapies.
Jimena Doval Clarke (AUS)
MCouns&PsychTh.
Jimena is a psychotherapist, group therapist and psychedelic-assisted therapist.
Following the completion of her masters in counselling and psychotherapy she worked in community mental health and facilitated therapeutic groups in women’s prisons with a focus on use and experience of violence. She currently works both in her private practice and in a psychiatric hospital specialising in the treatment of trauma and addiction. She has practiced as a group therapist and group facilitator for the last 4 years and is trained in the interpersonal approach to group psychotherapy. Jimena is currently part of a co-therapy dyad providing MDMA-assisted psychotherapy to patients with treatment-resistant PTSD. Jimena’s therapeutic orientation is fundamentally grounded in a humanistic approach with a focus on Rogerian Person-Centred Therapy and Existential Psychotherapy.
Francoise Bourzat holds an MA in Somatic Psychology from New College of California (San Francisco, 1990). She was an adjunct faculty in the East West Psychology Program at the California Institute of Integral Studies from 2012 to 2016. Since 1987, Francoise has apprenticed with shamans and healers in the U.S. and Mexico. In the last 25 years, she has traveled with groups to Mexico, incorporating her counseling practice experience with her knowledge of expanded states of consciousness where she partners with Mazatec healers in Sacred Mushrooms ceremonies. She also leads workshops and contributes to conferences internationally. Her book, Consciousness Medicine is available everywhere books are sold.
Trudi Hayes (AUS)
Trudi Hayes lives on Gumbaynggirr Country at Missabotti. She is a mother of two children and is an accredited Mental Health Social Worker by trade. Trudi has worked in community development for the past 25 years and currently works in private practice, as a facilitator in workshops, trainings and retreat using Somatic processing, Breath Medicine and Kinesiology. Trudi believes that through working with the body, we can move patterns of behaviour that no longer serve us, achieving a sense of freedom and supporting connection with self, others and the natural world.
Tania de Jong AM
LL.B (Hons), GradDipMus
Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. Tania has garnered an international reputation as an award-winning social entrepreneur, acclaimed soprano, inspirational speaker and storyteller, creative alchemist, philanthropist and spiritual journey woman. She is a passionate leader for social change. Her mission is to change the world, one voice at a time!
She regularly presents on creative, innovation, leadership, purpose, psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world across the business, government, creative arts and community sectors. Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and the With One Voice programs, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.
Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally. Her TED Talk has sparked global interest.
As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years. He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.
Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world. He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable.
Scott Edwards
Scott Edwards is the Joint General Manager of the Mind Medicine Australia Clinic. Previously he was Executive Officer of Mind Medicine Australia delivering the organisation’s Psychedelic-Assisted Therapy Training & Education program, including its world-leading Certificate in Psychedelic-Assisted Therapies program. He also worked on the strategy and implementation of MMA’s successful advocacy initiative to reschedule MDMA and psilocybin.
He has been working in adult education for over 15 years, designing and implementing programs in the music and healthcare fields. In addition, he is a somatic facilitator and breathwork practitioner, working with a variety of techniques to support and integrate expanded states of awareness for therapeutic outcomes. He is the co-founder of Breath Medicine.
Emma Park is a Functional Nutritionist and Psychotherapist with a deeply integrative approach to healing, bridging nutritional medicine, trauma-informed psychotherapy, breathwork, and nervous system regulation. She holds a Bachelor of Health Science in Nutritional Medicine and has completed advanced training in Compassionate Inquiry (Dr Gabor Maté), Psychedelic-Assisted Therapies through Mind Medicine Australia, and breathwork facilitation.
With a background spanning clinical practice, health education, and group facilitation, Emma brings a grounded, compassionate, and holistic perspective to mental health and wellbeing. She previously spent eight years as a clinical educator in the microbiome and gut health space, alongside delivering community health education programs in regional and remote Australia.
Emma is passionate about the intersection of nutrition, nervous system regulation, emotional healing, and human connection. Her work supports individuals to reconnect with authenticity, resilience, self-awareness, and a deeper sense of meaning within themselves and their lives.
* Please note that faculty is subject to change based on course curriculum, availability and to ensure that overall learning experience is enhanced for the student cohort.
Hear from our students
Course structure and contents
The course will take place over a period of 4 months with:
- 78 hours of face-to-face or webinar-based tuition and practical instruction
- 43 hours of additional reading, reflection and self-study expected of participants
- Pre-course reading schedule
- 14 online 3 hour sessions: delivered on Sundays, containing lectures with our world class faculty and practical skill development.
- One 6-day Intensive Retreat: with primary focus on practical learning and consolidation of therapeutic skills, working with videos of real sessions, role play, feedback on skills learning and further development guidance. The residential uses breathwork to allow participants to experience an altered state based therapy and apply the clinical skills they have developed during the course.
- Assessments: a quiz for each module, a self-reflection task, a written task and a video recorded role-play of a PAT scenario.
Core Course Content:
- History of Psychedelic-Assisted Therapy
- Key Concepts of Psychedelic-Assisted Therapy
- Essentials of Pharmacology & the REBUS Theory
- You, the Therapist
- Ethics, Diversity & Touch
- Screening and Preparation
- Psilocybin-Assisted Therapy
- MDMA-Assisted Therapy
- Ketamine-Assisted Psychotherapy
- Challenging Experiences & Integration
- Trauma & Psychedelic-Assisted Therapy
- Philosophy of Mind & Non-Materialist Perspectives
- Regulatory Framework for Psychedelic Medicine in Australia
- Microdosing
- Music for Psychedelic-Assisted Therapy
- Psychedelic-Assisted Therapy Practicum (Residential Training)
Course dates
Apply now for upcoming CPAT intakes:
All residentials after June 2026 are held in Victoria at the Yarra Valley Estate.
First residential (recommended for those in NSW, ACT, QLD and NZ)
Second residential (recommended for those in VIC, TAS, SA, WA and NT)
2026 Cohort 2: July 19 – November 22
First residential: November 5th – November 10th
Second residential: November 13th – November 18th
2027 Cohort 1: February 21 – June 20
First residential: May 31st – June 5th
Second residential: June 8th – June 13th
2027 Cohort 2: July 18 – November 21
First residential: November 4th – November 9th
Second residential: November 12th – November 17th
Residential location
Our residentials are set at the beautiful Yarra Valley Estate in Victoria's renowned Yarra Valley. This venue offers a peaceful natural setting that supports the depth of learning, reflection, and connection that sits at the heart of this program. Surrounded by the landscapes of the Yarra Valley, the estate provides an ideal environment for participants to immerse themselves fully in the training experience while connecting with a community dedicated to advancing safe, evidence-based breakthrough therapies.
All food menus are prepared in-house using fresh seasonal produce, organically grown onsite or locally sourced. Yarra Valley Estate supports a 'low food miles' ethos and a 'seed to plate philosophy'.
For participants who would prefer additional privacy during the week, we are offering a limited number of exclusive single rooms. A total of 15 single rooms are available and can be reserved for an additional fee of $900 for the full week. These rooms will be allocated on a first-come, first-served basis.
Testimonials
Download the testimonials from our previous intakes: Download pdf (360.0 KB) Last updated: May 18, 2026
Course accreditation
Mind Medicine Australia’s Certificate in Psychedelic-Assisted Therapies™ is accredited by the Australian Medical CPD Standard.
Psychiatrists & other Medical Doctors
CPAT™ is accredited for 113 hours of Educational Activity and 14 hours of Reviewing Performance, under the new CPD Program for Medical Practitioners. It has been peer-reviewed by an independent panel of psychiatrists.
Psychologists & other Healthcare Professionals
CPAT™ is accredited for 127 hours of CPD. It has been peer-reviewed by an independent panel of psychologists.
All our training courses and events may also be used to claim ongoing Continuing Professional Development (CPD) points in Australia through your professional colleges or associations. Please check with your professional membership body for the appropriate category and number of points.
Eligibility requirements
The CPAT™ course aims to build on skills already acquired and used by professionals working in the mental health field. The three main roles in administering PAT are the Prescriber, Primary Therapist and Secondary Therapist.
Note that this is not an entry level course that qualifies an individual to practice psychotherapy. Applicants are expected to already be qualified to practice in the mental healthcare field and have relevant clinical experience.
The CPAT™ course is available to a variety of mental healthcare professionals including:
- Psychiatrists
- Medical Practitioners
- Psychologists
- Registered Psychotherapists and Counsellors
- Nurses
- Social Workers
- Occupational Therapists
- Registered Allied Health Professionals
- Addiction Specialists
- Pharmacists
- Spiritual Carers
- Some Complementary Medicine Practitioners
Other relevant healthcare professionals may be considered.
Admission into the CPAT™ is dependent on several factors including potential role in PAT (prescriber, primary therapist, secondary therapist), professional qualifications, and capacity of the applicant to successfully undertake and complete the CPAT™. Preference will be given to applicants who have clinical experience in mental healthcare. Australian applicants who are registered with AHPRA or a relevant professional association are welcome to apply. Applicants from outside these categories are also encouraged to apply and will be assessed on their qualifications, experience, and commitment to the field.
Note that MMA believes that to be a Primary Therapist in PAT, the practitioner should have extensive psychotherapeutic experience, preferably with significant amounts of supervision, and is/has engaged in their own self-development (eg. therapy, experience in altered states).
Applicants who do not work in one of the above professions will be considered if they:
(A) are completing study/training to work in the mental health field
OR
(B) have substantial experience in altered state based work in non-clinical environments such as breathwork practitioners, indigenous healers, shamanic practitioners.
Please note that those from the above categories will receive a certificate of participation in place of a CPAT-prescriber or CPAT-therapist certificate of completion.
Fees and payment
Application fee: $250 (non-refundable)
plus
Course fee: $10950 (by instalments) or $9950 (upfront payment in full)
Financial assistance is available to those who are unable to afford the full fee. Click here for details.
*Fees may be tax-deductible depending on profession. Please speak to your tax agent for more information.
Payment Structure:
- $250 application fee collected at time of application plus upfront payment in full.
- One upfront payment of $9950 or 3 payments of $3650 will be issued (to be paid in full before course completion) upon acceptance into the course.
Please note that the first payment (of either $9950 or $3650 is required to secure your place in the course).
Payment Method:
- The $250 application fee will be processed by PayPal. You will be taken to the PayPal site upon completion of the application form.
- MMA will issue your invoice(s) for remaining course fees upon acceptance into the course.
CPATTM FAQs
Please read the FAQs below for Mind Medicine Australia’s (MMA) Certificate in Psychedelic-Assisted Therapies (CPAT)™. If you have further questions please contact MMA.
1. How many hours are required for the course each week?
Each week of the online course has a 3-hour class, with additional readings, experiential workshops and discussion exercises to support your learning.
We recommend allocating 6-7 hours/week to maximise the learnings and absorb the content.
2. When will I find out if I’ve been accepted into the course?
After receiving your application it will be reviewed within 3 business days. Admission interview times will be shared for applicants who meet the eligibility criteria that you can book within the following 1-2 weeks.
We review interviews at the end of each week. After you complete your admission interview you will be notified by the end of that week with an outcome. Payment in full or the first instalment will be required within 7 business days following an offer.
3. Is attendance required at all sessions?
Live attendance is not required for online sessions. We strongly encourage all students to attend as many sessions live as they can and ask questions and engage with the teachers and other students. All sessions will all be recorded for later viewing for those who cannot attend.
Attendance of the entire residential is required to complete the course.
4. What are the assessment requirements of the course?
The course has 4 assessment requirements:
- Module quizzes – each module has a 10-question quiz which covers the module’s learning outcomes.
- Self-reflection – a written self-reflective piece is completed after module 4 of the course.
- Written assessment – a written assessment piece is submitted at the end of the course. This assessment piece is different for prescribers and therapists. Prescribers will document a treatment protocol for either MDMA or psilocybin, and therapists will outline the therapeutic approach for a course of treatment.
- Video role play – a video role play of a preparation session is submitted at the end of the course.
5. What are the differences in the course for prescribers and therapists?
Prescribers and therapists complete the training together. All content is completed by all students.
This structure ensures that all clinicians seeking to work in PAT have a foundational understanding of all areas relevant to delivering these treatments.
Prescribers and therapists will complete different tasks in their final written assessment.
Note that prescribers who are also suitably trained to deliver therapy (such as psychiatrists) will be able to work as both a prescriber and a therapist upon completion of the course.
MMA has found that a diverse, multidisciplinary group of professionals significantly enhances the learning experience. It also leads to a strong network of like-minded professionals who often form clinical groups, networks and teams following the course.
6. Will MMA’s CPAT™ allow me to work in the PAT field?
With current regulations, Human Research Ethics Committees (HRECs) and the TGA are responsible for determining who can work as part of the multidisciplinary teams that are required to deliver psilocybin and MDMA-assisted therapy as part of the TGA’s Authorised Prescriber (AP) program. The current regulations require that PAT be delivered in a team of two for each client. There is one lead therapist role and one secondary therapist role. The lead therapist is currently required to be a clinical psychologist or psychiatrist. The secondary can be any health professional with registration from an industry body such as AHPRA, PACFA, ACA, CMA or AASW. Therapists in either role require specific training such as is provided by the CPAT™.
We can confirm that MMA’s CPAT™ is being accepted by both HRECs and the TGA as suitable training to allow clinicians to work in teams delivering psilocybin and MDMA-assisted therapy.
Ketamine-assisted psychotherapy (KAP) has less regulations around who can work to deliver treatment. CPAT™ graduates will be able to deliver KAP – either by prescribing themselves or partnering with a medical doctor who can prescribe.
7. Is CPAT™ accredited?
Certificate in Psychedelic-Assisted Therapies (CPAT™) has officially received Australian Medical CPD Standard (AMcpdS) accreditation! AMcpdS highlighted the value of this course in helping healthcare professionals make informed clinical decisions, including patient treatment options and referral processes. As Australia continues to lead the World in delivering these breakthrough therapies, by joining our CPAT course, you have the opportunity to make a real difference to patients and their healing journey.
Psychiatrists & other Medical Doctors
CPAT™ is accredited for 113 hours of Educational Activity and 14 hours of Reviewing Performance, under the new CPD Program for Medical Practitioners. It has been peer-reviewed by an independent panel of psychiatrists.
Psychologists & other Healthcare Professionals
CPAT™ is accredited for 127 hours of CPD. It has been peer-reviewed by an independent panel of psychologists.
All our training courses and events may also be used to claim ongoing Continuing Professional Development (CPD) points in Australia through your professional colleges or associations. Please check with your professional membership body for the appropriate category and number of points.
The training is also recognised by the HRECs and the TGA. MMA is actively working with the Australian and international educational and other organisations to support further accreditation of the course as it becomes possible to do so.
8. Is CPAT™ tax deductible?
If you work as a health professional where the training is relevant or educational then it is likely that you will be able to claim the training as a tax deduction, however, this is best discussed with your accountant to be certain.
Financial assistance
Financial assistance is available for our Certificate in Psychedelic-Assisted Therapies (CPAT)™!
Mind Medicine Australia, through the generosity of the Hunt Family Foundation, Perpetual, and other philanthropists, has raised approximately $100,000 per annum to support therapists and clinicians genuinely requiring support to engage in the CPAT training. The criteria for application are as follows:
· Genuine financial need
· From a profession with lower earning potential
· Demonstration of excellence
· Demonstration of commitment to this field of practice
· From a regional or rural area
Financial assistance is assessed upon application to join CPAT. Please note that small amounts of financial assistance can only be given to a few candidates in each cohort and are subject to availability of funds at time of application.
If you wish to apply for financial assistance, please apply now or book a call with a member of our team.
How to apply
Applications open:
Are open for 2026 intakes (applicants will be considered in order of receipt. We expect the program to be over-subscribed so please register early to avoid disappointment.)
Screening and interview/finalise applicants:
Your application is processed as received and contact is made directly to assess further and arrange an interview
Application process
Step 1: Complete the Application Form, including payment of your $250 application processing fee.
Step 2: Applications will be screened, and if successful invited to an interview. These are self-scheduled via our online portal
Step 3: If successful in your interview, you will be invited to join the course. You’ll be issued a student agreement and invoice for either $9950 upfront payment or 3 x $3650. Your place in the course will be secured upon receipt of your signed student agreement and your first payment.
Consulting Services
With PAT now being part of Australia's mental health system, Mind Medicine Australia supports clinicians in the set up and delivery of these life-changing treatments.
Our goal is to reduce the logistical burdens of developing the capacity to deliver PAT to your patients.
As a registered charity, our consulting services are offered at very reasonable rates, simply to cover our delivery costs.
Our approach combines access to world-class clinical knowledge, regulatory insights, financial expertise and emerging technologies to support clinicians in establishing transformative mental healthcare models.
Welcome to Mind Medicine Clinic and Centre of Excellence
Mind Medicine Australia Clinic and Centre of Excellence is a leading centre for the treatment of Post-Traumatic Stress Disorder and Treatment Resistant Depression in Melbourne.
We partner with highly trained and skilled clinical teams to provide evidence-based treatments, which are at the cutting edge of mental healthcare and are designed to help people who have tried other treatments without sufficient success.
CPATTM graduates can gain professional experience in psychedelic-assisted therapies at the clinic.
Mind Medicine Australia Clinic is a collaborative venture between Mind Medicine Australia and Psychennex.
Application Form
Contact us
Please use the contact form below to get in touch. Alternatively, send us an email to [email protected] or give us a call: 03 8679 6015.
Terms and Conditions
By submitting an enrolment application for the Certificate in Psychedelic-Assisted Therapies (CPAT), you acknowledge that you have read and accepted these Terms and Conditions.
1. Enrolment
- A non-refundable processing fee of $250 is required for your application to proceed further.
- You will be required to sign a Student Code of Conduct. This is required for your application to proceed.
- All information contained in your application and interview process is assumed to be correct and true to the best of your knowledge. In the event that any information is discovered to be false, your right to attend the course may be forfeited.
2 Fees
- Prices are inclusive of GST
- There is an Application fee of $250 (non-refundable)
- The Course fee is $10950 (or $9950 upfront payment in full)
Payment Structure: - $9950 upfront payment in full
Or - $10950 paid in instalments
- $3650 initial payment – due with the submission of your application
- $3650 second instalment payment – will be invoiced separately
- $3650 third and final instalment payment – will be invoiced separately
- If your application does not progress further than the interview stage, then your course fee will be refunded.
- On acceptance to the course, you will be required to pay the remainder of the full course fee as per the dates on the invoice sent to you. If you require a payment plan this can be arranged by contacting Mind Medicine Australia prior to the invoice being sent, or within 10 business days of the invoice date.
Where a student withdraws from study 28 days prior to commencement of a course they will receive a refund of their tuition fees paid less an administration fee of $50. There will be no refund of the application fee. - Failure to make payment/s by agreed dates or failing to enter a payment plan may result in the cancellation of your enrolment without a refund, Certificates cannot be issued until course fees are paid in full.
- The course fee is derived from the following factors:
- 90 hours of live face-to-face and webinar teaching
- Additional reading and teaching material supporting tuition
- Three intensives
- one non-residential weekend in Melbourne
- one residential weekend, accommodation and meals included
- one-week residential, accommodation and meals included
- Holotropic Breathwork workshop (during residential weekend): cost of Grof- trained therapist included
- Residential week provides direct, personalised skill development and practical exercises, assessment and risk management skills.
- Supervised practice/mentoring as required by the course*
- Monitoring of skill development through ongoing evaluation and coursework
3. Changes to the program
- Mind Medicine Australia reserves the right to make changes to the program with regard to teachers, content, dates and venues should unforeseen circumstances make this necessary. Mind Medicine Australia agrees to make every effort to maintain the overall standard and integrity of the program.
- Mind Medicine Australia is not liable to refund the costs of the program or make any compensation in the event of force majeure, excluding travel restrictions or limitations due to the COVID-19 crisis.
4. Student Code of Conduct
- You are required to sign and submit the Student Code of Conduct and agree to these Terms & Conditions.
5. Attendance
- You agree that you will make every effort to attend all lectures/webinars, to carry out any required set tasks and/or projects.
- You agree that attendance of the three intensives is essential to this program and not negotiable. Failure to attend will result in non-compliance with essential program elements being recorded.
- You agree that attendance at these events will be at your own risk, and that Mind Medicine Australia or any staff or teachers will not be liable in the event of accident or injury.
- If you fail to attend and complete required tasks and/or projects you will be asked to leave the program without compensation or reimbursement.
6. Confidentiality
- You agree that you will keep confidential any patient or client-sensitive material which may be part of discussions, demonstrations or teaching materials presented by anyone attending the program as well as program leaders and teachers.
- You agree that any personal information of fellow participants arising during the program will similarly be treated as confidential.
7. Ownership and intellectual property rights
- All CPAT materials, whether provided online or during face-to-face intensives, are owned by Mind Medicine Australia. All intellectual property rights in all materials available from Mind Medicine Australia, including the design, graphics and text of all printed materials and the audio of all webinars and podcasts, are owned by Mind Medicine Australia. The exception is any printed or audio material not created by Mind Medicine Australia or not produced specifically as part of the program.
- When you are given access to the CPAT, you are granted a non-exclusive, non- transferable and revocable licence to use the materials. No CPAT content may be copied, reproduced, uploaded, posted, displayed or linked to in any way, in whole or in part, without the Mind Medicine Australia’s prior permission. Any such use is strictly prohibited and will constitute an infringement of Mind Medicine Australia’s intellectual property rights.
- You agree that attending any webinars will be only for yourself, and that you will not permit any person not registered to sit in on the sessions.
- You agree that no part of any live or web-based event in the program will be recorded or transmitted by you in any way.
8. Breaches
- In the event of violations of any of the terms above, an evaluation of the severity of the breach will be made by the program leaders, following which:
- An attempt at remediation may be discussed with you, if this is unsuccessful, a formal warning will be issued.
- If the breach is deemed to be serious, you will be asked to leave the program without compensation or reimbursement.
9. Complaints
- Any complaints relating to the CPAT program will be handled fairly and confidentially in accordance with our Complaints Procedure. Complaints must be submitted in writing. Read our full complaints procedure here.
*Subject to regulatory requirements
Student Complaints Procedure
1. Purpose
This procedure sets out how students may raise concerns or complaints relating to their participation in the training program. The program is committed to maintaining a safe, ethical, and academically rigorous learning environment, particularly given the experiential, reflective, and psychologically demanding nature of psychedelic-assisted therapy training. Complaints will be managed fairly, promptly, and in accordance with industry standards for student welfare, procedural fairness, and academic integrity.
2. Scope
This procedure applies to complaints relating to course delivery, assessment processes (excluding formal academic appeals), teaching or facilitation practices, learning activities involving experiential or reflective components, interactions with staff, faculty, supervisors, or other students, administrative or communication matters, learning environment or psychological safety concerns, and perceived breaches of professional, ethical, or conduct standards. Matters involving immediate risk to safety or wellbeing should be reported directly to the course coordinator or relevant Mind Medicine Australia support services without delay. Complaints can be directed via email to [email protected] and [email protected]
3. Guiding Principles
Complaints are managed in line with our principles of justice, confidentiality, transparency, and non-retaliation. The training program recognises the additional sensitivity required in PAT education, where personal material, altered-state content, and therapeutic themes may arise. Students will not be disadvantaged or penalised for raising concerns in good faith.
4. Informal Resolution
Where appropriate, students are encouraged to seek informal resolution as a first step. This may involve discussing the concern with the relevant facilitator, supervisor, or staff member, or contacting the Course Coordinator or Head of Training for guidance. Informal resolution aims to address concerns early and collaboratively and does not prevent a student from later lodging a formal complaint. Students may choose to have a support person present.
5. Formal Complaints Process
If informal resolution is unsuccessful or not appropriate, a formal complaint may be lodged in writing. Complaints should be submitted via email to the designated complaints contact for the course and should include the student’s name and contact details, course and cohort, a clear description of the concern, relevant dates and parties involved, and any supporting documentation. Complaints will be acknowledged in writing within five business days. An appropriate senior staff member, independent from the matter where possible, will review the complaint. Additional information may be requested, and the student may be invited to provide further clarification. A written outcome will normally be provided within twenty business days. If delays are anticipated, the student will be informed.
Possible outcomes include clarification or explanation, acknowledgement of concerns, corrective or preventative action, referral to another policy or process, or recommendations for future practice improvements.
6. Appeals and External Pathways
If a student is dissatisfied with the outcome of a formal complaint, they may request a review by senior administrative leadership. Information on appropriate external bodies or ombudsman services will be provided where relevant.
7. Confidentiality and Records
All complaints are handled confidentially and stored securely in accordance with record-keeping requirements. Information is shared only on a need-to-know basis. De-identified data may be used to monitor themes and inform continuous improvement of the training program.
8. Student Support
The program acknowledges that raising a complaint within a PAT training context may be emotionally challenging. Students are encouraged to access support through course staff, student wellbeing services, or external supports as needed.